title: [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy].
authors.affiliation: Servicio de Farmacia, Hospital Universitario Severo Ochoa, Madrid, España.. handreailla@gmail.com.
authors.forename: Andrea
authors.initials: A
authors.lastname: Domínguez Gozalo
authors.affiliation: Servicio de Farmacia, Hospital Universitario Severo Ochoa, Madrid, España.. handreailla@gmail.com.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Hidalgo Correas
authors.affiliation: Servicio de Farmacia, Hospital Universitario Severo Ochoa, Madrid, España.. handreailla@gmail.com.
authors.forename: Elena
authors.initials: E
authors.lastname: García Benayas
authors.affiliation: Servicio de Farmacia, Hospital Universitario Severo Ochoa, Madrid, España.. handreailla@gmail.com.
authors.forename: Benito
authors.initials: B
authors.lastname: García Díaz
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols